Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 2
1990 1
1993 2
1997 1
1998 1
1999 1
2000 1
2002 1
2003 2
2004 1
2005 1
2006 5
2007 2
2008 5
2009 4
2010 4
2011 3
2012 5
2013 3
2014 3
2015 1
2017 1
2018 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.
Vermersch P, Brieva-Ruiz L, Fox RJ, Paul F, Ramio-Torrenta L, Schwab M, Moussy A, Mansfield C, Hermine O, Maciejowski M; AB07002 Study Group. Vermersch P, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Feb 21;9(3):e1148. doi: 10.1212/NXI.0000000000001148. Print 2022 May. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35190477 Free PMC article. Clinical Trial.
Placebo-controlled trial of oral laquinimod for multiple sclerosis.
Comi G, Jeffery D, Kappos L, Montalban X, Boyko A, Rocca MA, Filippi M; ALLEGRO Study Group. Comi G, et al. N Engl J Med. 2012 Mar 15;366(11):1000-9. doi: 10.1056/NEJMoa1104318. N Engl J Med. 2012. PMID: 22417253 Free article. Clinical Trial.
Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation.
Beltrán E, Obermeier B, Moser M, Coret F, Simó-Castelló M, Boscá I, Pérez-Miralles F, Villar LM, Senel M, Tumani H, Hohlfeld R, Casanova B, Dornmair K. Beltrán E, et al. Among authors: coret f. Brain. 2014 Oct;137(Pt 10):2703-14. doi: 10.1093/brain/awu205. Epub 2014 Jul 23. Brain. 2014. PMID: 25060097
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
Beltrán E, Hernández A, Lafuente EM, Coret F, Simó-Castelló M, Boscá I, Pérez-Miralles FC, Burgal M, Casanova B. Beltrán E, et al. Among authors: coret f. J Neuroimmunol. 2012 Jun 15;247(1-2):63-9. doi: 10.1016/j.jneuroim.2012.03.013. Epub 2012 Apr 11. J Neuroimmunol. 2012. PMID: 22498100
CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
Villar LM, Masterman T, Casanova B, Gómez-Rial J, Espiño M, Sádaba MC, González-Porqué P, Coret F, Alvarez-Cermeño JC. Villar LM, et al. Among authors: coret f. J Neuroimmunol. 2009 Jun 25;211(1-2):101-4. doi: 10.1016/j.jneuroim.2009.03.003. Epub 2009 May 13. J Neuroimmunol. 2009. PMID: 19443047
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
Villar LM, Casanova B, Ouamara N, Comabella M, Jalili F, Leppert D, de Andrés C, Izquierdo G, Arroyo R, Avşar T, Lapin SV, Johnson T, Montalbán X, Fernández O, Álvarez-Lafuente R, Masterman D, García-Sánchez MI, Coret F, Siva A, Evdoshenko E, Álvarez-Cermeño JC, Bar-Or A. Villar LM, et al. Among authors: coret f. Ann Neurol. 2014 Aug;76(2):231-40. doi: 10.1002/ana.24190. Epub 2014 Jul 2. Ann Neurol. 2014. PMID: 24909126
The effect of intravenous immunoglobulin on neuromyelitis optica.
Magraner MJ, Coret F, Casanova B. Magraner MJ, et al. Among authors: coret f. Neurologia. 2013 Mar;28(2):65-72. doi: 10.1016/j.nrl.2012.03.014. Epub 2012 Jul 28. Neurologia. 2013. PMID: 22841880 Free article. English, Spanish.
51 results